A detailed history of Summit Trail Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 113,684 shares of PFE stock, worth $2.98 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
113,684
Previous 135,741 16.25%
Holding current value
$2.98 Million
Previous $3.8 Million 13.38%
% of portfolio
0.08%
Previous 0.1%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $610,978 - $692,369
-22,057 Reduced 16.25%
113,684 $3.29 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $1.95 Million - $2.29 Million
77,293 Added 132.24%
135,741 $3.8 Million
Q1 2024

Apr 23, 2024

BUY
$25.89 - $29.73 $349,773 - $401,652
13,510 Added 30.06%
58,448 $1.62 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $449,880 - $584,344
-17,217 Reduced 27.7%
44,938 $1.29 Million
Q3 2023

Oct 30, 2023

BUY
$32.09 - $37.51 $7,669 - $8,964
239 Added 0.39%
62,155 $2.06 Million
Q2 2023

Jul 25, 2023

BUY
$36.12 - $41.79 $468,512 - $542,058
12,971 Added 26.5%
61,916 $2.27 Million
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $218,496 - $284,450
5,547 Added 12.78%
48,945 $2 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $193,469 - $252,553
4,634 Added 11.95%
43,398 $2.22 Million
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $176,484 - $215,442
-4,033 Reduced 9.42%
38,764 $1.7 Million
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $499,453 - $592,194
10,734 Added 33.48%
42,797 $2.24 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $216,123 - $267,803
4,724 Added 17.28%
32,063 $1.66 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $24,254 - $35,953
587 Added 2.19%
27,339 $1.61 Million
Q3 2021

Nov 16, 2021

BUY
$39.25 - $50.42 $94,200 - $121,008
2,400 Added 9.86%
26,752 $1.15 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $25,101 - $28,435
699 Added 2.96%
24,352 $954,000
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $56,263 - $63,453
-1,680 Reduced 6.63%
23,653 $857,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $847,895 - $1.08 Million
25,333 New
25,333 $933,000
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $735,361 - $862,747
-23,161 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $28,192 - $34,201
936 Added 4.21%
23,161 $757,000
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $600,741 - $858,329
22,225 New
22,225 $725,000
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $621,891 - $705,767
-18,891 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $81,679 - $105,914
2,514 Added 15.35%
18,891 $679,000
Q2 2019

Aug 08, 2019

BUY
$36.98 - $41.52 $22,816 - $25,617
617 Added 3.91%
16,377 $709,000
Q1 2019

May 16, 2019

BUY
$37.5 - $41.2 $591,000 - $649,312
15,760 New
15,760 $669,000
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $1.98 Million - $2.12 Million
-60,172 Closed
0 $0
Q1 2018

May 22, 2018

SELL
$31.91 - $37.02 $45.2 Million - $52.4 Million
-1,415,910 Reduced 95.92%
60,172 $1.48 Million
Q1 2018

May 21, 2018

BUY
$31.91 - $37.02 $45.6 Million - $52.9 Million
1,429,293 Added 3054.76%
1,476,082 $1.48 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $1.56 Million - $1.65 Million
46,789
46,789 $1.72 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.